Summary

The Federal Office for Economic Supply (FOES) is discontinuing newsletter notices on the list of supply disruptions for human medicines effective 15 June 2026. The reason is the digitalization of the reporting office, which enables automated and daily data updates. Updated information on supply disruptions will henceforth be published directly and daily on the FOES website. Interested parties are asked to consult the website regularly.

Persons

  • Federal Office for Economic Supply (FOES)

Topics

  • Digitalization of public services
  • Medicine supply
  • Supply security

Clarus Lead

The transition signals a shift from reactive to proactive information distribution: instead of periodic newsletter notifications, stakeholders now receive continuously updated data in real-time. This reduces information gaps and enables faster responses to medicine supply shortages – a critical factor for health security and supply continuity.

Detailed Summary

The reporting office for vital human medicines of the FOES has modernized its information infrastructure. The previous practice of communicating supply disruptions via regularly sent newsletter notices is being replaced by a digital system that provides automatically updated daily data directly on the FOES website.

This transformation enables higher update frequency and eliminates delays from manual data processing. Pharmacies, hospitals, physicians, and other healthcare actors can now independently and promptly inform themselves about current supply disruptions without relying on newsletter cycles.

Key Statements

  • Newsletter notices on supply disruptions will be discontinued as of 15 June 2026
  • Automated, daily data updates on the FOES website replace the previous system
  • Stakeholders must consult the website regularly for current information

Critical Questions

  1. Data Quality & Validation: What automated control mechanisms ensure that the daily updated supply disruption data is correct and complete?

  2. Accessibility & Digital Divide: How is it ensured that all relevant actors (particularly smaller pharmacies, medical practices) have regular access to the website and can overcome technical barriers?

  3. Transition Risks: Is there an increased risk during the transition phase that critical supply disruptions are overlooked because actors do not promptly discover the new website-based information source?

  4. Proactive Notification: Are there plans for optional push notifications (email, SMS, API feeds) for critical supply disruptions to avoid relying on regular website queries?

  5. Automation Transparency: According to which criteria is a situation automatically classified and published as a "supply disruption"?


Sources

Primary Source: Newsletter notice from the Federal Office for Economic Supply (FOES) – https://www.news.admin.ch/de/newnsb/KSSgM6Do-mEw

Verification Status: ✓ 15 June 2026


This text was created with the support of an AI model. Editorial responsibility: clarus.news | Fact-checking: 15 June 2026